Product Information

FENOFIBRATE 40 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $5.7857 per EA under NDC 00378439077. Its NADAC has been published 197 times since Jun 22, 2022.

The High Outlier badge above means this manufacturer's average price in the fenofibrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

FENOFIBRATE 40 MG TABLET

fenofibrate
$5.7857per EA
High Outlier

Strength

40 mg/1

NDC

00378439077

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

FENOFIBRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA204475

On Market Since

6/23/2016

Price Statistics

The NADAC for FENOFIBRATE 40 MG TABLET has been published 197 times since Jun 22, 2022, and over the history we have for it it has declined 12.0%. The table below summarizes its recorded NADAC range and movement.

Current price$5.7857 per EA
All-time high$6.5784 (Apr 12, 2023)
All-time low$5.1212 (Aug 21, 2024)
52-week high$6.5576
52-week low$5.7857
Median price$6.0558
Average price$6.1294
Largest weekly change-9.3% (Apr 19, 2023)
Weeks tracked197
Tracking sinceJun 22, 2022

Price History

1W

0.0%

1M

-0.5%

3M

-4.5%

6M

-5.2%

1Y

-11.3%

3Y

-3.1%

5Y

N/A

All

-12.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the fenofibrate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of FENOFIBRATE 40 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 40 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $5.7857 per EA (NDC 00378439077), effective Jun 24, 2026.

How has the price of FENOFIBRATE 40 MG TABLET changed over time?

Over the history we have for it, the NADAC for FENOFIBRATE 40 MG TABLET has declined 12.0%. It has been tracked across 197 weekly CMS publications since Jun 22, 2022.

What are the highest and lowest recorded NADAC prices for FENOFIBRATE 40 MG TABLET?

Since Jun 22, 2022, the NADAC for FENOFIBRATE 40 MG TABLET has ranged from a low of $5.1212 (Aug 21, 2024) to a high of $6.5784 (Apr 12, 2023), with a median of $6.0558 per EA.

Are there cheaper alternatives to FENOFIBRATE 40 MG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of FENOFIBRATE 40 MG TABLET, so no direct lower-cost alternative is listed.

Who manufactures FENOFIBRATE 40 MG TABLET?

FENOFIBRATE 40 MG TABLET (NDC 00378439077) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.